CIBC Private Wealth Group
LKFT

CIBC Private Wealth Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

CIBC Private Wealth Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$283 – 3186
2024
Q2 		$283 Buy
+11
New +$312 ﹤0.01% 3027

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CIBC Private Wealth Group's LKFT Position: Q3 2024 in Review

CIBC Private Wealth Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2024, closing a stake of 11 shares — an estimated $283 sold.

CIBC Private Wealth Group first reported a position in LKFT in Q2 2024 and held it in 1 quarter. The position peaked at $283 in Q2 2024. 79 funds tracked by Wall St. Rank hold LKFT as of Q3 2024.

  • CIBC Private Wealth Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 11 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2024, an estimated $283.
  • CIBC Private Wealth Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2024 and held it in 1 quarter.
  • CIBC Private Wealth Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $283 in Q2 2024.
  • 79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2024.

Based on CIBC Private Wealth Group's 13F filing for Q3 2024, filed 13 Nov 2024.